G. Arteel, V. Mostert, H. Oubrahim, K. Briviba, J. Abel et al., après nos résultats d'extrapoler que lors de l'oxydation des LDL en présence d'Ebselen l'effet antioxydant de celui-ci est en partit lié à la régénération de la vitamine E. Cependant les résultats obtenus avec le trolox vont dans le sens de l'hypothèse formulée par Laas 1 Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration, Biological chemistry, vol.379, pp.8-9, 1998.

A. Ascherio and W. Willett, Are Body Iron Stores Related to the Risk of Coronary Heart Disease?, New England Journal of Medicine, vol.330, issue.16, pp.1152-1154, 1994.
DOI : 10.1056/NEJM199404213301611

B. Ml, A. Maria, J. Kieffer, J. Harney, and P. Larsen, Substitution of cystéine for selenocysteine in type I iodotyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation, Endocrinology, vol.131, pp.1848-52, 1992.

J. Bonnet and A. Elias, Athérosclérose et plaque d'athérome. Encyclopédie médicale et chirurgicale(Elsevier Paris) Cardiologie et angéiologie, pp.11-605

M. Brown and J. Goldstein, A receptor-mediated pathway for cholesterol homeostasis, Science, vol.232, issue.4746, pp.34-47, 1986.
DOI : 10.1126/science.3513311

R. Burk and K. Hill, Regulation of selenoproteins. Annual review of nutrition, pp.65-81, 1993.
DOI : 10.1146/annurev.nutr.13.1.65

R. Burk, K. Hill, J. Awad, J. Morrow, T. Kato et al., Pathogenesis of diquat-induced liver necrosis in selenium deficient rats : assessment of the roles of lipid peroxidetion and selenoprotein P, Hepatology, vol.21, issue.2, pp.561-569, 1995.

R. Burk, In vivo 7 5 Se binding to human plasma proteins after administration of 7 5 SeO32???, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.372, issue.2, pp.255-265, 1974.
DOI : 10.1016/0304-4165(74)90188-3

P. Chappuis, Les oligo-éléments en médecine et biologie Editions médicales internationales; Lavoisier tee & doc, pp.450-451, 1991.

K. Demuth, I. Myara, and N. Moatti, Biologie de la cellule endothéliale et athérogenése. · · Annales de biologie clinique, pp.171-189, 1995.

M. Diaz, B. Frei, J. Vita, and J. Keaney, Antioxidants and atherosclerotic heart disease, The New England Journal of Medicine, vol.337, issue.6, pp.408-416, 1997.

V. Ducros, F. Laporte, N. Belin, A. David, and A. Favier, Selenium determination in human plasma lipoprotein fractions by mass spectrometry analysis, Journal of Inorganic Biochemistry, vol.81, issue.1-2
DOI : 10.1016/S0162-0134(00)00071-4

V. Ducros, M. J. Richard, and A. Favier, The distribution of selenium in human plasma proteins for 24 hours after ingestion of 74Se (in sodium selenite form), Journal of Inorganic Biochemistry, vol.55, issue.3, pp.157-163, 1994.
DOI : 10.1016/0162-0134(94)85016-X

V. Ducros and A. Favier, Gas chromatographic???mass spectrometric method for the determination of selenium in biological samples, Journal of Chromatography B: Biomedical Sciences and Applications, vol.583, issue.1, pp.35-44, 1992.
DOI : 10.1016/0378-4347(92)80342-N

E. Marzouki and A. , Propriété physicochimiques de complexes du cuivre, modèles synthétiques de la superoxyde dismutase, Thèse de chimie, 1993.

H. Esterbauer, J. Gebicki, H. Puhl, and G. Jurgens, The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free radical in biology & medicine, pp.341-390, 1992.

H. Esterbauer, G. Striegl, H. Puhl, and M. Roheneder, Oxidation of Human Low Density Lipoprotein, Free Radical Research Communications, vol.252, issue.1, pp.67-75, 1989.
DOI : 10.3109/10715768909073429

A. Favier, Le stress oxydant: intérêt de sa mise en évidence en biologie médicale et problèmes posés par le choix d'un marqueur, Annales de biologie clinique, vol.55, issue.1, pp.9-16, 1997.

E. Ferguson, J. Singh, R. Hogg, N. Kalyanaraman, and B. , The mechanism of apolipoprotein B- 1 OO thiol depletion during oxidative modification of low-density lipoprotein, Archives of Biochemistry and Biophysics, vol.3412, pp.287-294, 1997.

J. Ferrieres, D. Blazy-ph, P. Bernadet, D. Blazy, and L. , Lipoprotéines oxydées et athérogénèse. Cahier de nutrition diététique, p.13, 1992.

A. Giebauf, E. Steiner, and H. Esterbauer, Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1256, issue.2, pp.221-232, 1995.
DOI : 10.1016/0005-2760(95)00024-7

A. Graham, Cellular Thiol Production and Oxidation of Low-Density Lipoprotein, Free Radical Research, vol.95, issue.6, pp.611-621, 1998.
DOI : 10.1007/BF02536182

W. Gunzler, H. Kremers, and F. , An improved coupled test for glutathion peroxidase in blood, Z. Klin Chem Klin Biochem, vol.12, pp.444-448, 1974.

I. Harrison, D. Littlejohn, and G. Fell, Distribution of selenium in human blood plasma and serum, The Analyst, vol.121, issue.2, pp.189-194, 1996.
DOI : 10.1039/an9962100189

J. Heinecke, Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis, Current Opinion in Lipidology, vol.8, issue.5, pp.268-274, 1997.
DOI : 10.1097/00041433-199710000-00005

C. Hennekens, J. Buring, and J. Manson, Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. The new Englandjournal of médecine, pp.1145-1154, 1996.

D. Holben and A. Smith, The Diverse Role of Selenium within Selenoproteins, Journal of the American Dietetic Association, vol.99, issue.7, pp.836-843, 1999.
DOI : 10.1016/S0002-8223(99)00198-4

P. Holvoet and D. Callen, Oxidised lipoproteins in atherosclerosis and thrornbosis, FASEB J, vol.8, issue.82, pp.1279-1284, 1994.

M. Iwatsuki, N. E. Stone, and D. , Darley-usmar V. a-Tocopherol mediated peroxidation in the copper and met myoglobin induced oxidation of human low density lipoprotein: The influence of lipid hydroperoxides, FEES, vol.360, pp.271-276, 1995.

F. Kok, Decreased Selenium Levels in Acute Myocardial Infarction, JAMA: The Journal of the American Medical Association, vol.261, issue.8, pp.1161-1164, 1989.
DOI : 10.1001/jama.1989.03420080081035

D. Kromhout, Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective, Lipids, vol.304, issue.S1, pp.827-831, 1999.
DOI : 10.1007/BF02562225

M. Kuzuya, K. Yamada, . Hayashi, C. Funaki, M. Naito et al., Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1123, issue.3, pp.334-341, 1992.
DOI : 10.1016/0005-2760(92)90015-N

A. Lass, P. Witting, R. Stocker, and H. Esterbauer, Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: antioxidant actions in addition to hydroperoxide-reducing activity, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1303, issue.2, pp.111-118, 1996.
DOI : 10.1016/0005-2760(96)00088-4

M. Leist, S. Maurer, M. Schultz, A. Elsner, D. Gawlik et al., Cytoprotection against lipid hydroperoxides correlates with increased glutathione peroxidase activities, but not selenium uptake from different selenocompounds, Biological Trace Element Research, vol.35, issue.2, pp.159-174, 1999.
DOI : 10.1007/BF02784404

Y. Lim, M. Cha, H. Kim, T. Uhm, J. Park et al., Removals of Hydrogen Peroxide and Hydroxyl Radical by Thiol-Specific Antioxidant Protein as a Possible Role in Vivo, Biochemical and Biophysical Research Communications, vol.192, issue.1, pp.273-280, 1993.
DOI : 10.1006/bbrc.1993.1410

J. Lodge, M. Traber, and L. Packer, Thiol chelation of Cu 2 + By dihydrolipoic acid prevents human low density lipoprotein peroxydation, Free Radical Biology and Medicine, vol.253, pp.287-297, 1998.

S. Low and M. Berry, Knowing when not to stop: selenocysteine incorporation in eukaryotes, Trends in Biochemical Sciences, vol.21, issue.6, pp.203-208, 1996.
DOI : 10.1016/S0968-0004(96)80016-8

S. Lynch and B. Frei, Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1345, issue.2, pp.215-221, 1997.
DOI : 10.1016/S0005-2760(96)00182-8

S. Lynch and B. Frei, Reduction of Copper, but Not Iron, by Human Low Density Lipoprotein (LDL): IMPLICATIONS FOR METAL ION-DEPENDENT OXIDATIVE MODIFICATION OF LDL, Journal of Biological Chemistry, vol.270, issue.10, pp.5158-5163, 1995.
DOI : 10.1074/jbc.270.10.5158

L. A. Daniels, Selenium metabolism and bioavailability, Biological Trace Element Research, vol.48, issue.Suppl 7, pp.185-199, 1996.
DOI : 10.1007/BF02784430

N. Miller, C. Rice-evans, V. Gopinathan, M. Davies, and A. Milner, A new automated method for estimating plasma antioxydant activity and its application to the investigation of antioxidant status in premature neonates. Free radicals and antioxydants in nutrition, pp.153-168, 1993.

S. Morse, H. Ralston, and H. Olcott, Selenium determination in human serum lipoprotein fractions by neutron activation analysis, Analytical Biochemistry, vol.49, issue.2, pp.598-601, 1972.
DOI : 10.1016/0003-2697(72)90470-8

T. Motoyama, M. Miki, M. Mina, M. Takahashi, and N. E. , Synergistic inhibition of oxidation in dispersed phosphatidylcholine liposomes by a combination of vitamin E and cysteine, Archives of Biochemistry and Biophysics, vol.270, issue.2, pp.655-661, 1989.
DOI : 10.1016/0003-9861(89)90548-1

D. Mustacich and G. Powis, Thioredoxin reductase, Biochemical Journal, vol.346, issue.1, pp.1-8, 2000.
DOI : 10.1042/bj3460001

E. Niki, [3] Free radical initiators as source of water- or lipid-soluble peroxyl radicals, Methods in Enzymology, vol.186, pp.100-108, 1990.
DOI : 10.1016/0076-6879(90)86095-D

N. Noguchi, G. Naohiro, and N. E. , Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1213, issue.2, pp.176-182, 1994.
DOI : 10.1016/0005-2760(94)90024-8

N. Noguchi, Y. Yoshida, H. Kaneda, Y. Yamamoto, and N. E. , Action of ebselen as an antioxidant against lipid peroxidation, Biochemical Pharmacology, vol.44, issue.1, pp.39-44, 1992.
DOI : 10.1016/0006-2952(92)90035-H

S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac, Oxidants and antioxidants in atherogenesis: an appraisal, Journal oflipid research, vol.40, pp.2143-2157, 1999.

B. H. Patterson, L. A. Zech, and C. Swanson, Levander 0 A. Kinetic modeling of sélénium in humans using stable isotope tracers, Journal trace element electrolytes health discease, vol.7, pp.117-120, 1993.

R. Patterson and D. Leake, Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH, FEBS Letters, vol.212, issue.3, pp.317-321, 1998.
DOI : 10.1016/S0014-5793(98)01002-3

P. Pietinen, E. Vartiainen, R. Seppanen, A. Aro, and P. Puska, Changes in Diet in Finland from 1972 to 1992: Impact on Coronary Heart Disease Risk, Preventive Medicine, vol.25, issue.3, pp.243-250, 1996.
DOI : 10.1006/pmed.1996.0053

P. Reaven, A. Khouw, W. Beltz, S. Parthasarathy, and J. Witztum, Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.13, issue.4, pp.590-600, 1993.
DOI : 10.1161/01.ATV.13.4.590

K. Retsky, K. Chen, J. Zeind, and B. Frei, Inhibition of copper-induced oxidation by vitamine C is associated with decreased copper binding to LDL ans 2-oxohistidine formation. Free radical biology and medicine, pp.90-98, 1999.

R. Evans, C. Leake, D. Bruckdorfer, R. Diplock, and A. , Pratical approaches to low density lipoprotein oxidation : whys, wherefores and pitfalls. Free radical research, pp.25285-311, 1996.

G. Rotilio and L. Calabrese, EPR study of Cu(II) complexes of tridentate amino acids, Archives of Biochemistry and Biophysics, vol.143, issue.1, pp.218-225, 1971.
DOI : 10.1016/0003-9861(71)90202-5

J. Salonen, R. Salonen, K. Seppanen, M. Kantola, S. Suntioinen et al., Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis., BMJ, vol.302, issue.6779, pp.756-760, 1991.
DOI : 10.1136/bmj.302.6779.756

N. Santanam and S. Parthasarathy, cellular cysteine generation does not contribute to the initiation ofLDL oxidation, Journal of Lipid Research, vol.36, pp.2203-2211, 1995.

H. Siest, V. Sharov, L. Klotz, and K. Briviba, Glutathion peroxydase protects against peroxynitrite mediated oxidations. The journal of biological chemistry, pp.27812-27817, 1997.

N. Stephens, A. Parsons, P. Schofield, F. Kelly, K. Cheeseman et al., Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), The Lancet, vol.347, issue.9004, pp.781-786, 1996.
DOI : 10.1016/S0140-6736(96)90866-1

J. Thomas, P. Geiger, and A. Girotti, Lethal damage to endothelial cells by oxidized low density lipoprotein : role of selenoperoxidases in in cytoprotection against lipid hydroperoxideand iron mediated reactions, Journal of lipid research, vol.34, pp.79-490, 1993.

F. Ursini and A. Bindoli, The role of selenium peroxidases in the protection against oxidative damage of membranes, Chemistry and Physics of Lipids, vol.44, issue.2-4, pp.255-276, 1987.
DOI : 10.1016/0009-3084(87)90053-3

A. Viega-crespo, Selenium status and cardiovascular risk factors in populations from different portuguese regions. Natural antioxidants and food quality in atherosclerosis and cancer prevention, pp.188-194

J. A. Vinson, J. M. Stella, and T. Flanagan, Selenium yeast is an effective in vitro and in vivo antioxidant and hypolipemic agent in normal hamsters, Nutrition Research, vol.18, issue.4, pp.735-742, 1998.
DOI : 10.1016/S0271-5317(98)00059-1

J. Virtamo, E. Valkeila, G. Alfthan, S. Punsar, J. Huttunen et al., SERUM SELENIUM AND THE RISK OF CORONARY HEART DISEASE AND STROKE, American Journal of Epidemiology, vol.122, issue.2, pp.276-282, 1985.
DOI : 10.1093/oxfordjournals.aje.a114099

P. Wagner and J. Heinecke, Copper ions promote peroxydation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B 1 OO, but they are reduced at other sites on LDL, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.1711, pp.3338-3346, 1997.

J. Witztun, The oxidation hypothesis of atherosclerosis, The Lancet, vol.344, issue.8925, pp.793-795, 1994.
DOI : 10.1016/S0140-6736(94)92346-9